FDA Adverse Event Summary report: N

ADVIA CENTAUR XP HCV ASSAY

MDR report key: 2062303 · Received April 19, 2011

Report

Report Number
1219913-2011-00052
Date Received
April 19, 2011
Date of Event
March 18, 2011
Report Date
March 25, 2011
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Product Code
MZO
PMA / PMN Number
P030056
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE DISCORDANT ADVIA CENTAUR XP HCV RESULT IS UNKNOWN. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED. THE INSTRUCTION FOR USE (IFU) LIMITATION SECTION STATES: "THE RESULTS FROM THIS OR ANY OTHER DIAGNOSTIC KIT SHOULD BE USED AND INTERPRETED ONLY IN THE CONTEXT OF THE OVERALL CLINICAL PICTURE. (B)(4)."

Description of Event or Problem · 1

(B)(6) ADVIA CENTAUR XP HCV RESULTS WERE OBTAINED ON A PATIENT SAMPLE. THE PATIENT SAMPLE WAS TESTED ON TWO OTHER ALTERNATE METHODS AND THE RESULTS WERE (B)(6). PATIENT TREATMENT WAS NOT ALTERED OR PRESCRIBED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR XP HCV RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR XP HCV ASSAY HEPATITIS C VIRUS (ANTI-HCV) ASSAY MZO SIEMENS HEALTHCARE DIAGNOSTICS, INC. N/A 220

Patients

Seq Age Sex Outcome Treatment
1